Biocaptiva Limited

BIOCAPTIVA is an award-winning biotechnology company based in Edinburgh, dedicated to revolutionising liquid biopsy and nucleic acid (NA) extraction. Harnessing our proprietary msX™ polymer technology, we are addressing critical challenges in the liquid biopsy market, empowering breakthroughs in genetic disease detection, diagnosis, monitoring, and treatment. Our advanced extraction method ensures unparalleled cell-free NA yield and quality, driving progress in precision medicine and multi-omics research- Our innovative, biocompatible NA-binding polymers offer unmatched benefits: Customisable coatings for diverse substrate formats, including bead-based systems and automated workflows: Effortlessly captures cell-free NAs from simple and complex solutions without the need for additional reagents or preservatives: Prioritises rare cell-free NA fragments by minimising high molecular weight NA capture, enabling comprehensive sample profiling: Safeguards bound NAs at room temperature for up to 90 days: Processes sample volumes ranging from millilitres to litres, offering exceptional scalability. At BIOCAPTIVA, we are driving transformative advancements in biotechnology to unlock new horizons in genetic disease management and multi-omics research. Together, we’re shaping the future of precision medicine.